Repository logo
 

TMEM106B amyloid filaments in the Biondi bodies of ependymal cells.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Biondi bodies are filamentous amyloid inclusions of unknown composition in ependymal cells of the choroid plexuses, ependymal cells lining cerebral ventricles and ependymal cells of the central canal of the spinal cord. Their formation is age-dependent and they are commonly associated with a variety of neurodegenerative conditions, including Alzheimer's disease and Lewy body disorders. Here, we show that Biondi bodies are strongly immunoreactive with TMEM239, an antibody specific for inclusions of transmembrane protein 106B (TMEM106B). Biondi bodies were labelled by both this antibody and the amyloid dye pFTAA. Many Biondi bodies were also labelled for TMEM106B and the lysosomal markers Hexosaminidase A and Cathepsin D. By transmission immuno-electron microscopy, Biondi bodies of choroid plexuses were decorated by TMEM239 and were associated with structures that resembled residual bodies or secondary lysosomes. By electron cryo-microscopy, TMEM106B filaments from Biondi bodies of choroid plexuses were similar (Biondi variant), but not identical, to the fold I that was previously identified in filaments from brain parenchyma.

Description

Acknowledgements: We are grateful to the patients’ families for donating brain tissues. We thank R. Richardson, N. Maynard and K. Cox for technical support. This work was supported by the Center for Electron Microscopy of the Indiana University School of Medicine. It was also supported by the Electron Microscopy Facility of the MRC Laboratory of Molecular Biology. We thank J. Grimmett, T. Darling and I. Clayson for help with high-performance computing

Journal Title

Acta Neuropathol

Conference Name

Journal ISSN

0001-6322
1432-0533

Volume Title

148

Publisher

Springer Science and Business Media LLC

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Medical Research Council (MR/P01271X/1)